Cambrex Corp (CBM.N)
CBM.N on New York Stock Exchange
14.30USD
1 Aug 2013
14.30USD
1 Aug 2013
Price Change (% chg)
$-0.35 (-2.39%)
$-0.35 (-2.39%)
Prev Close
$14.65
$14.65
Open
$14.50
$14.50
Day's High
$14.50
$14.50
Day's Low
$14.26
$14.26
Volume
15,010
15,010
Avg. Vol
40,074
40,074
52-wk High
$15.62
$15.62
52-wk Low
$8.85
$8.85
About
Cambrex Corporation (Cambrex) is a life sciences company, which provides products and services, which accelerate and improve the development and commercialization of new and generic therapeutics. The Company’s business is consisted of the custom development and manufacture of pharmaceutical ingredients derived from organic... (more)
Overall
| Beta: | 1.38 |
| Market Cap (Mil.): | $439.96 |
| Shares Outstanding (Mil.): | 30.03 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| CBM.N | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 6.63 | 37.93 | 37.76 |
| EPS (TTM): | 2.21 | -- | -- |
| ROI: | 22.22 | 19.48 | 18.76 |
| ROE: | 47.41 | 20.17 | 19.59 |
Competitors
| Price | Change | |
|---|---|---|
| Albany Molecular Research, Inc. (AMRI.OQ) | $12.69 | -0.02 |
| GeoPharma, Inc. (GORXQ.PK) | $0.01 | -0.00 |
| Natural Alternatives International, Inc. (NAII.OQ) | $4.87 | -0.02 |
| Crucell N.V. (CRCL.AS) | -- | -- |
| Clariant AG (CLN.VX) | CHF14.47 | -0.04 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Trading Report for (CBM). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
|
$58.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Stock Traders Daily
|
$495.00
|
|
Provider: Pechala's Reports
|
$15.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

